# Low-Dose Naltrexone in Combination With Standard Treatment in Women With Endometriosis

> **NCT03970330** · PHASE3 · TERMINATED · sponsor: **Milton S. Hershey Medical Center** · enrollment: 9 (actual)

## Conditions studied

- Endometriosis

## Interventions

- **DRUG:** Naltrexone
- **DRUG:** Norethindrone Acetate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03970330
- **Lead sponsor:** Milton S. Hershey Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-01-16
- **Primary completion:** 2021-06-21
- **Final completion:** 2021-06-21
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Original PI left institution, lack of funding to continue
- **Last updated:** 2022-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03970330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03970330, "Low-Dose Naltrexone in Combination With Standard Treatment in Women With Endometriosis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03970330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*